Jilin Province Huinan Changlong Bio-pharmacy Company Limited (HKG:8049)

HKG:8049 Revenue

Jilin Province Huinan Changlong Bio-pharmacy Company had revenue of 435.05M CNY in the half year ending June 30, 2026, with 10.67% growth. This brings the company's revenue in the last twelve months to 898.05M, down -3.12% year-over-year. In the year 2025, Jilin Province Huinan Changlong Bio-pharmacy Company had annual revenue of 901.87M with 2.35% growth.

• Revenue (ttm): 898.05M CNY
• Revenue Growth: -3.12%
• P/S Ratio: 1.28
• Revenue / Employee: 811.25K CNY
• Employees: 1,107
• Market Cap: 1.33B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	901.87M	20.71M	2.35%
Dec 31, 2024	881.16M	39.61M	4.71%
Dec 31, 2023	841.55M	-41.00K	-
Dec 31, 2022	841.59M	136.13M	19.30%
Dec 31, 2021	705.46M	83.21M	13.37%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 20, 2026

Data Sources Report a data error